Daily Stock List
El Capitan Precious Metals, Inc. (ECPN)
PennyTrader Publisher and AllPennyStocks reported previously on El Capitan Precious Metals, Inc. (ECPN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
El Capitan Precious Metals, Inc. is an exploration stage company principally engaged in the exploration of precious metals and other minerals. The Company primarily holds interest in the El Capitan gold-silver property located near Capitan, New Mexico. El Capitan Precious Metals' shares trade on the OTC Bulletin Board. The Company has their headquarters in Scottsdale, Arizona.
El Capitan Precious Metals' primary asset is their wholly owned subsidiary El Capitan, Ltd., an Arizona corporation. This subsidiary holds the 100 percent equity interest in the aforementioned El Capitan property. The El Capitan deposit has been known as a potential iron ore resource for a number of decades. The U.S. Bureau of Mines drilled approximately 140 shallow holes through the outcropping, shallow-dipping magnetite skarn deposit in 1944 and 1948.
The El Capitan property consists of 354 Bureau of Land Management (BLM) lode claims and four patented claims. The claim block is in Lincoln County, New Mexico and occupies approximately 3,000 acres in townships T 7 S, T 8 S, and range R 14 E. A number of recovery methods have been utilized in extracting ore from the El Capitan property. These methods include the alkali fusion method, silver lead collection, as well as carbon pre-roast with silver-lead recovery.
At the end of February 2013, El Capitan Precious Metals announced that they obtained results from a well-respected metallurgical lab that used pre-treatment of the ore and the industry accepted method of cyanide vat leaching. The resulting assays, obtained under "Chain of Custody" procedures, demonstrated substantial values of gold along with lesser amounts of other precious metals.
The Company, to increase the value of their mining property, added this method of precious metal recovery process to the silver-lead recovery process (the Sundancer Method) currently being used. To maximize the recovery of all precious metals, El Capitan is working with the metallurgical lab to develop further an encompassing recovery process that will include cyanidation recovery and the silver-lead process.
El Capitan Precious Metals, Inc. (ECPN), closed Friday's trading session at $0.17, down 8.60%, on 168,016 volume with 25 trades. The average volume for the last 60 days is 247,009 and the stock's 52-week low/high is $0.131/$0.52.
Tasman Metals Ltd. (TAS)
Pro-Edge, Streetwise Reports, SmarTrend Newsletters, FNNO Newsletters, SmallCap Network, and Red Chip reported this month on Tasman Metals Ltd. (TAS), and we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Tasman Metals Ltd. is a mineral exploration and development company with headquarters in Vancouver, British Columbia. They concentrate on Rare Earth Elements (REE's) in the European region. The Company's exploration portfolio has the capacity to deliver "high-tech" metals from politically stable, mining friendly jurisdictions with developed infrastructure. Tasman Metals' lists on the TSX Venture Exchange under the symbol "TSM" and the NYSE-MKT under the symbol "TAS".
The Company's Norra Karr project in Sweden is one of the most significant heavy REE resources in the world. The resource is unusually low in radioactive metals relative to peer projects. It has less than 15 ppm each of uranium and thorium. The mine site will not require any special permitting or monitoring for radioactivity. Furthermore, the transport of concentrates will not require radioactive permitting.
The Norra Karr project lies in southern Sweden, and roads, power and water are at the site. Active rail and port facilities are close as well. Norra Karr is a nepheline syenite that contains a large inferred REE Mineral Resource of 60.5 Million Tonnes averaging 0.54 percent TREO (total rare earth oxides) with 53 percent HREO (heavy rare earth oxides).
This week, Mr. Mark Saxon, President & CEO of Tasman Metals, announced that the Company has been granted their Mining Lease for the Norra Karr heavy rare earth element (REE) project in Sweden. The Mining Lease gives Tasman the full mineral rights for the Norra Karr project for an initial period of 25 years. This is renewed subsequently, automatically, in 10-year increments if the mine is in operation. The Swedish Mining Inspectorate (Bergsstaten) granted the lease.
The Norra Karr project is one of the two NI 43-101 compliant REE resources within the EU, both 100 percent owned by Tasman Metals. Norra Karr lies 15km NNE of the township of Gränna and 300km SW of the capital Stockholm in mixed forestry and farming land. Norra Karr is one of the largest and most economically strong projects among its peers. This is because of the high contribution of the high value critical REE's (dysprosium (Dy), yttrium (Y), neodymium (Nd), and terbium (Tb)).
Tasman Metals Ltd. (TAS), closed Friday's trading session at $0.8421, up 10.80%, on 38,420 volume. The average volume for the last 60 days is 37,420 and the stock's 52-week low/high is $0.50/$2.04.
Brazil Minerals, Inc. (BMIX)
PennyStocks Forever and Greenbackers reported recently on Brazil Minerals, Inc. (BMIX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Brazil Minerals, Inc. is a precious minerals producer with corporate headquarters in Beverly Hills, California. The Company's vision is to become a premier diversified mining company focused on Brazil and they have resources and assets in the country. Brazil Minerals has their Brazilian headquarters in São Paulo. They also have an operational office in Belo Horizonte, the capital of the state of Minas Gerais.
The Company's mining assets include an interest in Duas Barras; this is a diamond and gold producing mine located in the state of Minas Gerais. Their assets also include a 100 percent ownership of a gold producing area, Borba, in the State of Amazonas, Brazil. Additionally, Brazil Minerals has a pipeline of opportunities in diamonds, gold, and other minerals throughout Brazil.
The Company expects to commence operating their newly acquired dredging vessel at Duas Barras during Q2 2013. They believe this would increase the revenue potential of the operation. During Q2 2013, they expect to have initial geochemical results from numerous samples collected by their geological team at the Borba Project area. This is so they can plan further developments in the region. Furthermore, their management team is actively reviewing several other exploratory Brazilian territories and mining concessions in phosphate, zinc, lead, and niobium, in addition to adding some specific, additional diamond and gold assets.
This week, Brazil Minerals reported their financial results ($USD) for the three months ended March 31, 2013. The Company had Revenues of $5,763 and a Pretax Operating Loss of $176,825. Their Cash Outflows from Operations was $224,729, and their Cash and Cash Equivalents was $637,160.
Mr. Marc Fogassa, Brazil Minerals (BMIX) Chairman and Chief Executive Officer, stated, "As of March 31, 2013, BMIX had only the original 20 percent right to cash flows from just diamond sales in Duas Barras, and the first quarter of any given year is essentially a non-producing quarter for alluvial operators in Minas Gerais due to the heavy rain season. However, during Q2 2013, BMIX concluded the acquisition of a larger 55 percent stake in Duas Barras, which now includes gold revenues as well. Therefore we expect continual improvement in our financial results starting in Q2 2013."
Brazil Minerals, Inc. (BMIX), closed Friday's trading session at $0.55, down 5.74%, on 418,339 volume with 158 trades. The average volume for the last 60 days is 233,355 and the stock's 52-week low/high is $0.40/$1.10.
Ginguro Exploration, Inc. (GEG.V)
We are reporting on Ginguro Exploration, Inc. (GEG.V) today, here at the QualityStocks Daily Newsletter.
Listed on the TSX Venture Exchange, Ginguro Exploration, Inc. is a mineral exploration company. They are focusing on the advancement of their Pardo paleo-placer gold property, located in Pardo Township in northern Ontario. Ginguro Exploration is presently targeting the first large-scale Precambrian paleo-placer gold deposit in North America, at their Pardo, as well as Four Corners, and Grigg/Stobie Gold properties. The Company has their headquarters in Sudbury, Ontario.
Pertaining to the Pardo Property, it is a 113 sq. km. paleo-placer Gold property 65 km northeast of Sudbury. It has Gold bearing conglomerate "reefs" possessing large tonnage potential. Ginguro Exploration has a 100 percent interest in 80 sq. kms of claims. They can earn a 70 percent interest in an additional 33 sq. kms of claims pursuant to an option agreement with Endurance Gold.
The Company's Four Corners Property (100 percent owned) is a 59 sq. km property located approximately 70 kms northeast of Sudbury. It is identified as having a similar stratigraphy to the Pardo Property. Their Grigg/Stobie Property (100 percent owned) is a 68 sq. kms property located approximately 55 kms northeast of Sudbury; it is also identified as having a similar stratigraphy to Pardo. Grigg/Stobie is characterized by extensive reworked conglomerates, with large zones of enriched uranium mineralization.
In April, Ginguro Exploration provided an update on recent corporate and Pardo project activities. Over the course of the past winter, they undertook a wide-ranging geotechnical program of drill core review, drawing from their vast archive of drill core from the Pardo Project of over 340 individual drill holes. Under the supervision of Dr. Lawrence Minter, a very systematic re-logging of selected Pardo intersections has been continuing. As part of this process, the ancient surfaces upon which gold was deposited are being correlated to each other. Furthermore, Ginguro has identified several areas where gold mineralization occurs at surface under shallow overburden.
In mid-February of this year, Ginguro was successful in acquiring two important claims totaling approximately 448 hectares and extending for more than three kilometers along the Pardo gold trend, to the north of the existing claims.
Ginguro Exploration, Inc. (GEG.V), closed Friday's trading session at $0.05, up 11.11%, on 20,000 volume. The stock's 52-week low/high is $0.04/$0.14.
SuperDirectories, Inc. (SDIR)
Epic Stock Picks, EpicVIP Group, AskSlapper, TradeThesePicks, Investor News Source, and Penny Stocks VIP reported earlier on SuperDirectories, Inc. (SDIR), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Founded in 1999, SuperDirectories, Inc. engages in the design and development of a searchable directory of selected contents from the Internet. The Company offers a searchable directory of selected topics presented on the Internet at superdirectories.com. Their site provides links to different search engines to assist users in making searches via other search engines. SuperDirectories has their corporate headquarters in Merrill, New York. The Company's shares trade on the OTC Markets' OTCQB.
SuperDirectories is the largest 'Human-edited' directory on the internet. The structuring of the database is with 'Full-Text' searchable categories, cross-references and links to selected websites. The primary source of revenues will be from Pay-per-Click (PPC) fees, websites listing fees on their directories, advertising (banners), as well as affiliates and associates programs with Ecommerce websites.
The objectives of SuperDirectories are to have the most complete and comprehensive directory on the Internet, to provide internet users a friendly 'Full Text' search of their database, and to provide internet users a friendly 'Voice Command' option to select pages on the Company's website.
The Company's objectives also include providing internet users an on-line friendly variety of instructional 'Animated Tutorials' to surf the internet, and use email and other computer related operations. Their objectives additionally include providing internet users an 'Email Translation' service.
SuperDirectories intention is for their service directory to go live around the fourth quarter of this fiscal year or the first quarter of next fiscal year. Currently, the Company has five servers in operation - two in Watertown, New York at facilities operated by Westelcom, two in Gatineau, Quebec, and one at facilities operated by MCI in Montreal, Quebec. Their intention is to install a sixth server at a Westelcom facility in Plattsburgh, New York this fall.
In 2013, SuperDirectories (contingent on available funding) intends to begin building an administrative staff that they will need to manage their business as the Company prepares to move from a developmental to operational mode.
SuperDirectories, Inc. (SDIR), closed Friday's trading session at $0.0092, up 2.22%, on 4,345,512 volume with 58 trades. The average volume for the last 60 days is 371,000 and the stock's 52-week low/high is $0.0015/$0.75.
United Resource Holdings Group, Inc. (URHG)
We are highlighting United Resource Holdings Group, Inc. (URHG), here at the QualityStocks Daily Newsletter.
Based in Reno, Nevada, United Resource Holdings Group, Inc. focuses on gold, silver and copper mining and other natural resources. The Company operates by way of their two subsidiaries, Dun Glen Mining Corp. and United Milling & Refining Corp. The Company focuses on the acquisition of mining equipment, mineral-bearing materials, and the development of gold and other precious commodity projects that demonstrate a reasonable probability for near-term production and revenue. United Resource Holdings Group lists on the OTC Pink Current Information.
In addition, the Company holds a controlling interest in a beneficiation process plant that recovers precious metals from mineral ores and ore concentrates on behalf of their captive mining properties and on behalf of third-party mining companies. Their Dun Glen subsidiary is an exploration and mining company. Their United Milling & Refining subsidiary is a downstream precious metals and mineral ore processing company.
Dun Glen focuses on the acquisition and development of gold and other precious metal commodity projects. Dun Glen Mining has the rights to numerous patented and unpatented mining claims located in Township 33N, Range 36E, Sections 15 and 16, Pershing County, Nevada. This area is referred to as the Dun Glen Mine. It is Dun Glen Mining's sole placer mining property at this time.
United Milling & Refining focuses on the beneficiation and smelting of gold and other precious metals. United Milling & Refining operates a 32,000 square foot facility; they provide their services to small and mid-sized, independent mining operations throughout North America.
United Resource Holdings Group announced in March of this year that United Minerals Investment Corp., a wholly owned subsidiary of the Company, executed a letter agreement for the financing, acquisition and processing of mineral-bearing materials. United Minerals entered into a letter agreement with Northern Gold Producers, LLC regarding the financing, acquisition and processing of certain mineral-bearing materials that may undergo identification by United Minerals or their Nevada-based processing partner.
Moreover, concerning Dun Glen Mining, this subsidiary of the Company has the rights to numerous patented and unpatented mining claims located in the aforementioned Township 33N. The Dun Glen Mine is due east of, and is next to, the Sunrise Minerals, LLC, gold-silver open-pit mining operation (Sunrise Mine) that has been in operation for over five years.
United Resource Holdings Group, Inc. (URHG), closed Friday's trading session at $0.1685, up 2.12%, on 86,250 volume with 15 trades. The average volume for the last 60 days is 77,822 and the stock's 52-week low/high is $0.126/$0.9475.
WebSafety, Inc. (WBSI)
Psionic Matrix reported this month on WebSafety, Inc. (WBSI), StockMister, Stock Exploder, The Stock Psycho, Top Gun, Damn Good Penny Picks, Top Best Pennystocks, SmallCapAllStars, HotPennyInvest.com, SimplyBestPennyStocks did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.
Based in Newport Beach, California, WebSafety, Inc.'s goal is to market and sell through the internet a range of software applications and services for cell phones. These applications and services would enable parents or other caregivers to monitor and be notified of occurrences of predator advances, cyber bullying, and pornography received on cell phones. The Company's intention is to market the products and services by developing relationships with "trusted" sources consisting of child protection advocacy groups. These include church, school, as well as civic organizations. WebSafety lists on the OTC Markets' OTCQB.
Additionally, the Company's cell phone application restricts text messaging while driving and provides location information to parents through utilizing GPS (global positioning system) technology. Moreover, WebSafety's intention is to explore opportunities to enter into strategic revenue sharing partnerships with companies having synergy with the Company's products. These partners may include auto insurers and cell phone manufacturers.
The mobile software application supports devices using Android and BlackBerry wireless operating systems. The application operates on all four of the major wireless carriers in the United States; it operates on the three major wireless carriers in Canada.
The Company's advanced database technology can search more than 22,000 words, terms, and phrases that mean danger. WebSafety's technology is the only mobile parental control that contains the world's largest word recognition library of its kind. The alerts instantly notify instances of sexting, texting while driving, cyber- bullying, pornography, or predatory conduct.
In April, WebSafety announced that the U.S. Patent Office issued to the Company a patent for inhibiting a cell phone's ability to text, email or web browse in a moving vehicle.
Mr. Rowland W. Day II, Chief Executive Officer of WebSafety, stated, "We are pleased that this Patent has now been issued. This validates the technology and will allow us to expand our technology and marketing to protect vehicle operators and their guests from the dangers of texting, emailing and web browsing in a moving vehicle."
WebSafety, Inc. (WBSI), closed Friday's trading session at $0.0013, up 18.18%, on 56,281,592 volume with 144 trades. The average volume for the last 60 days is 12,262,458 and the stock's 52-week low/high is $0.0008/$0.036.
Claude Resources, Inc. (CRJ.TO)
Today we are reporting on Claude Resources, Inc. (CRJ.TO), here at the QualityStocks Daily Newsletter.
Claude Resources, Inc. is a gold mining and exploration company that lists on the Toronto Stock Exchange. The Company has their Seabee Gold Operation in northeastern Saskatchewan. In addition, Claude Resources owns 100 percent of the Madsen Property in the prolific Red Lake gold camp of northwestern Ontario. They also own 100 percent of the Amisk Gold Project in northeastern Saskatchewan. The Company has their corporate headquarters in Saskatoon, Saskatchewan.
Claude Resources has an asset base located entirely in Canada. The Company has produced more than 1,031,000 ounces of gold from their Seabee Gold Operation since 1991. The Seabee Gold Operation consists of two producing mines, the Seabee Gold Mine - since 1991 - and the Santoy 8 Gold Mine - since January 2011. The Seabee Gold Operation is in the La Ronge Mining District at the north end of Laonil Lake approximately 125 kilometers northeast of the town of La Ronge, Saskatchewan and approximately 150 kilometers northwest of Flin Flon, Manitoba. The Seabee property is 100 percent owned and operated by Claude Resources. It consists of 17,200 hectares; it is supported by full infrastructure.
The Madsen Gold Project is in Red Lake, Ontario. The property consists of a 4,000-hectare land package with four past producing mines on the property. The Company's Amisk Gold Project is in Saskatchewan near Flin Flon, Manitoba. The property consists of 40,373 hectares.
This week, Claude Resources provided results from their recently completed 2013 first quarter drill program at the Santoy Mine Complex within their 100 percent-owned Seabee Gold Operation. Recent drilling at Santoy Gap has extended the mineralized system down-plunge to 650 meters depth. At Santoy 8, it has extended the system 400 meters below the base of the existing inferred resource. These step-out drill intercepts considerably expand the footprint of the Santoy Mine Complex. They are of a materially higher grade than the current reserve and resource base.
The 2013 surface drill program consisted of three step-out drill holes targeting the down-plunge extension of the Santoy Gap and Santoy 8 deposits. At December 31, 2012, Santoy Gap hosted an indicated resource of 281,200 ounces at 8.80 grams of gold per tonne and an inferred resource of 356,900 ounces at 5.92 grams of gold per tonne.
The Company anticipates the completion of a detailed mine design for the Santoy Gap during the third quarter. Based on results, they expect to convert a major portion of the resource base into the reserve category. Claude Resources anticipates initial production from Santoy Gap starting in the second half of 2014. All 2013 underground and surface drill results will undergo incorporation into an updated National Instrument 43-101 compliant resource statement to be released by the end of this calendar year.
Claude Resources, Inc. (CRJ.TO), closed Friday's trading session at $0.265, down 1.85%, on 601,076 volume. The stock's 52-week low/high is $0.26/$0.92.
StreamTrack, Inc. (STTK)
The QualityStocks Daily Newsletter would like to spotlight StreamTrack, Inc. (STTK). Today, The Aristocrat Group Corp. closed trading at $0.50, even for the day. The stock’s average daily volume over the past 60 days is 1,166, and its 52-week low/high is $0.29/$5.28.
StreamTrack, Inc. (STTK), a digital media and technology services company, provides audio and video streaming and advertising services through its RadioLoyalty™ Platform to a global group of internet and terrestrial radio stations, internet radio guides, and other broadcast content providers. The company's platform powers a web-based and mobile player that manages streaming audio and video content, social media engagement, and ad serving.
StreamTrack offers its platform directly to broadcasters and integrates or white labels its technologies with web-based internet radio guides and other web-based content providers. With StreamTrack technology, broadcasters and publishers are able to maximize their revenue while decreasing expenses, while advertisers are provided with a cost-effective means to reach their target audience from one source at scale.
WatchThis™, StreamTrack's patent-pending technology designed to provide web, mobile, and IP television streaming services that are e-commerce enabled within streamed content, could revolutionize the entertainment industry by combining original network content with interactive product placement. Recognizing the convergence of traditional televised advertisement and internet technology, StreamTrack is advancing its WatchThis™ technology to lead the revolution taking place.
StreamTrack is dedicated to continually creating and managing innovative technology products to provide broadcasters and content owners the most advanced solutions available in the marketplace. Fully committed to also increasing and protecting shareholder value, the management team carefully executes operational, development, and marketing programs with the primary aim of maximizing the company's growth potential and profitability. Disclaimer
StreamTrack, Inc. Company Blog
StreamTrack, Inc. News:
StreamTrack Announces Alliance to Potentially Reach Over 300 Million Registered PPTV Users
StreamTrack Announces Operating Results for Second Quarter Fiscal 2013
StreamTrack Announces Stock Ticker Symbol Change to "STTK"
VistaGen Therapeutics, Inc. (VSTA)
The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $0.7999, up 25.59%, on 2,500 volume with 1 trade. The stock’s average daily volume over the past 60 days is 3,116, and its 52-week low/high is $0.06/$1.52.
VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs.
VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.
By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.
Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.
AV-101, VistaGen's lead small molecule prodrug candidate has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.
Neuropathic pain affects approximately 1.8 million people in the U.S. alone. Although the current active AV-101 IND is for the treatment of neuropathic pain, VistaGen's development plan and regulatory strategy for AV-101 has been designed to allow its Phase 1 safety studies to support Phase 2 development for depression, epilepsy, Huntington's Disease and Parkinson's disease, indications for which there is now supporting preclinical efficacy data. To date, VistaGen has been awarded over $8.5 million from the U.S. National Institutes of Health (NIH) for development of AV-101.
VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer
VistaGen Therapeutics, Inc. Company Blog
VistaGen Therapeutics, Inc. News:
VistaGen Therapeutics and Duke University Publish Results on Production of Functional 3D Human Heart Tissue
VistaGen Announces $36 Million Strategic Financing Agreement
VistaGen Therapeutics to Present Enhancements and Expanded Validation of LiverSafe 3D™ at Society of Toxicology's 52nd Annual Meeting
DoMark Internatioxnal, Inc. (DOMK)
The QualityStocks Daily Newsletter would like to spotlight DoMark International, Inc. (DOMK). Today, DoMark International, Inc. closed trading at $0.075, up 7.14%, on 134,500 volume with 13 trades. The stock’s average daily volume over the past 60 days is 158,821 and its 52-week low/high is $0.0322/$3.63.
DoMark International, Inc. (DOMK) is focused on researching, evaluating, and acquiring profitable private firms in the business segments of sports, technology, medical, energy, and business services. By providing the financial and human capital necessary to deal with overwhelming administrative, planning, governance, compliance, and regulatory challenges, its newly acquired partners can focus their energy and flourish.
Through its wholly owned subsidiary, SolaWerks, Inc., DoMark is committed to revolutionizing the efficiency and capabilities of a new generation of mobile devices. The subsidiary's current focus is on developing and distributing the SolaPad, a combined cover and charging system for Apple's iPad, and the SolaCase, a combined cover and charging system for all versions of Apple's iPhone.
Musclefoot, Inc., another wholly owned subsidiary of DoMark, is engaged in the distribution, marketing, and sale of Barefoot Science, the revolutionary patented foot care system designed to relieve foot and back pain as well as improve athletic performance. With a strong commitment to customer service and security, DoMark plans to expand its marketing relationships across a far broader product set.
The management team has positioned the company to capitalize on emerging opportunities by working with the world's most forward-thinking companies to develop and market game-changing products with the promise of long-term financial growth. Leveraging the expertise of its team, the company continues to evaluate acquisition candidates and products targeting underserved markets to increase its growth potential. Disclaimer
DoMark International, Inc. Blog
DoMark International, Inc. News:
Investment in Game Changing New Multi-Media Games Product Developer Imagic Ltd by Smartphone Accessory Supplier DoMark International
DoMark International Announces Move to Protect Shareholders by Cancelling 50k Preferred Shares, 5.74M Common A Shares
DoMark Announces Global Launch for There New IRcharger Cover for All Apple iPhone and Samsung Galaxy Products
VentriPoint Diagnostics Ltd. (VPTDF)
The QualityStocks Daily Newsletter would like to spotlight VentriPoint Diagnostics Ltd. (VPTDF). Today, VentriPoint Diagnostics Ltd. closed trading at $0.09, up 2.97%, on 7,000 volume with 2 trades. The stock’s average daily volume over the past 60 days is 24,809, and its 52-week low/high is $0.073/$0.163.
VentriPoint Diagnostics Ltd. (VPTDF) leverages knowledge-based techniques to make heart analysis more convenient and less expensive. Having already installed multiple VMS™ analysis systems for heart testing in leading cardiac centers in Europe, Canada and the United States, the company is currently focused on expanding the applications of its technology beyond congenital heart disease in adults and children.
VMS™ is the first cost-effective and accurate diagnostic tool for measuring right ventricle heart function. The company designed its analysis system to be used for all major heart diseases, including pulmonary hypertension, cardiovascular disease, and heart failure. Canada and Europe (CE Mark) have granted approval for the sale of the VMS™ diagnostic tool, and VentriPoint is pursuing the US-FDA approval through the 510(k) process.
The company’s VMS™ analysis systems eliminate all the disadvantages of an MRI scan, including a long wait list, the one-hour scan time, the claustrophobic environment, the requirement of a general anesthetic for children, the lengthy heart analysis process, and the need for a second trip to the hospital. Offering better efficiency and cost savings, VMS™ offers the healthcare industry a superior method of heart visualization.
The management team executing VentriPoint’s business strategy retains extensive experience in both healthcare technology and business development. Many expansion opportunities exist for the company’s technology with a total market potential exceeding $1 billion. As a leader in the clinical diagnostics market, the company is well positioned to meet the well-defined clinical need for efficient, accurate, and inexpensive heart analysis. Disclaimer
VentriPoint Diagnostics Ltd. Company Blog
VentriPoint Diagnostics Ltd. News:
VentriPoint Announces Closing of Private Placement and Proposed Issuance of Shares for Debt
VentriPoint Announces Private Placements
VentriPoint Receives CE Mark for Major Expansion of Its VMS™ Platform for Right Heart Analysis
StreamTrack, a digital media and technology services company, provides audio and video streaming and advertising services through its RadioLoyalty™ Platform to a global group of internet and terrestrial radio stations, internet radio guides, and other broadcast content providers. The company’s platform powers a web-based and mobile player that manages streaming audio and video content, social media engagement, and ad serving.
StreamTrack offers its platform directly to broadcasters and integrates or white labels its technologies with web-based internet radio guides and other web-based content providers. With StreamTrack technology, broadcasters and publishers are able to maximize their revenue while decreasing expenses, while advertisers are provided with a cost-effective means to reach their target audience from one source at scale.
WatchThis™, StreamTrack’s patent-pending technology designed to provide web, mobile, and IP television streaming services that are e-commerce enabled within streamed content, could revolutionize the entertainment industry by combining original network content with interactive product placement. Recognizing the convergence of traditional televised advertisement and internet technology, StreamTrack is advancing its WatchThis™ technology to lead the revolution taking place.
StreamTrack is dedicated to continually creating and managing innovative technology products to provide broadcasters and content owners the most advanced solutions available in the marketplace. Fully committed to also increasing and protecting shareholder value, the management team carefully executes operational, development, and marketing programs with the primary aim of maximizing the company’s growth potential and profitability.
Some call it the Frankenstein revolution, but the fact is that it heralds what may become one of the most important developments in 21st Century medical science. It’s the use of stem cell technology to build living organisms in the laboratory, paving the way for possible customized biological organ and tissue factories that could someday eliminate the need for donors. No longer science fiction, the technology to produce viable tissues and body parts is already under development.
However, there is side to the science, represented by California biotech company VistaGen Therapeutics, that is separate but no less important than the generation of replacement parts for damaged organs. It’s the creation of living tissues for the testing of drugs, allowing a degree of detailed testing and analysis superior in many ways to traditional animal tests or human trials. It’s a form of testing done right in the lab, observable at the cellular and even molecular level, providing detail unavailable any other way. In addition, it can be done at the earliest stages in drug development, long before committing to the time and expense of formal trials or actual marketing, potentially saving major pharmaceutical companies millions or even billions of dollars.
VistaGen Therapeutics has developed a proprietary pluripotent stem cell technology for use in the discovery, rescue, and development of novel drug candidates. These are drugs that have been shown to be effective, but which had to be shelved late in the game due to heart or liver toxicity, a common problem with new drugs. A pharmaceutical company may have spent a fortune on developing a drug, but it now sits on the shelf, its possible value essentially lost.
Using its Human Clinical Trials in a Test Tube bioassay system, VistaGen can now take such drugs and potentially solve the toxicity issues right in the lab. The company’s strategy is to use their technology to build a pipeline of drug rescue variants, proprietary new small molecule drug candidates, in collaboration with contract drug development service companies. VistaGen plans to have economic participation rights to each and every drug it develops, which should benefit its bottom line as well as its shareholders.
For additional information, visit www.VistaGen.com
Russia, like so much of Europe, Asia, and other parts of the world, has been wrestling with slow growth. For many countries, including the U.S., the problem has been a growing debt crisis, and the associated attempts to get expenditures back in line with income. It’s a crisis often blamed on years of over-spending politicians who have gradually learned to trade fiscal responsibility for short-term political expediency. But in the case of Russia, where the debt to GDP ratio is low, the challenge has been about dealing with an over-dependency on oil and gas exports in a world suddenly flush with new resources, such as from the U.S., coupled with the ongoing challenge of restructuring inefficient economic and political institutions.
For Rafarma Pharmaceuticals, having a government under growing pressure to build economic and social infrastructure while stimulating the economy has been a major benefit. RAFA is a rapidly growing Russian-based multi-product pharmaceutical company that is being actively encouraged by the government in an effort to develop Russia’s pharmaceutical independence from western-based big pharma. To this end, the company has constructed the most technologically advanced pharmaceutical plant in Russia, with the goal of producing a range of generic and alternative pharmaceutical products available for sale at “mass market” prices for the domestic market. The plan is to dramatically reduce prices on certain pharmaceutical products by 30%-40%.
The timing is right, with Russia’s pharmaceutical industry emerging as one of the world’s fastest growing markets. RAFA’s marketing plans have already led to the company being considered the principal supplier to the Russian Public Health system and the Russian Army. The company is currently fully GDP compliant, and GCP and GMP standards are in their final stages of approval. The company is also working to become GLP and GAP compliant, at which time Rafarma Pharmaceuticals will be the only Russian-based pharmaceutical company representing the complete cycle of the world’s top pharmaceutical standards.
For more information, visit www.rafarma.us
Cyclone Power Technologies, a developer of the all-fuel, clean-tech Cyclone Engine, has signed a Memorandum of Understanding (MOU) with McGill University of Quebec, Canada, to develop alternative solid fuel combustion systems for micro-sized power units.
Cyclone has identified a key market for its external combustion technology in the application of providing universal portable power for next generation battery charging as well as mechanical shaft power for autonomous robots, exoskeletons, and bio-medical systems.
Per the agreement, Cyclone will utilize McGill’s research in the controlled combustion of energy dense solid fuels to achieve system size constraints for portable power and robotics which require high power density thermal sources and combustion systems. Cyclone calls McGill’s research “one of the most advanced programs in the discipline … and can possibly lead to massive technological leaps in generating heat to run micro-scale external combustion engines.”
“This early-staged project is part of a larger plan to expand Cyclone’s base technology beyond our current programs and into additional cutting edge markets for the future — integrating ourselves with Lithium Ion batteries, fuels cells and advanced robotics,” Christopher Nelson, president of Cyclone, stated in the press release. “These growth sectors range from enhancing human capabilities, to human-robotic interaction in medical devices, to even space exploration. It is a logical maturing of Cyclone’s founding mission of innovation to pursue these forward looking opportunities, especially with leading research institutions like McGill.”
The MOU stems from a previous relationship between Cyclone and McGill, in which they collaborated on a project submission to the Department of Energy’s ARPAe program.
For more information visit www.cyclonepower.com
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Announces Filing of Proxy Statement Supplement and New Annual Meeting Date
- Consorteum Holdings, Inc. (CSRH) Enters Partnership Agreement With KO Entertainment, Inc.
- Cardium Therapeutics, Inc. (CXM) Announces Generx Publication In Molecular Therapy
- DoMark International, Inc. (DOMK) Smartphone Accessory Supplier, Makes Major Investment in Promising New Multi-Media Games Product Developer Imagic Ltd
- GNCC Capital, Inc. (GNCP) Reaches Agreement to Acquire White Hills Gold Properties
- GlobalWise Investments, Inc. (GWIV) Adds Toshiba Business Solutions AZ/CO as New Channel Sales Partner
- International Stem Cell Corp. (ISCO) to Present at Two Upcoming Investor Conferences
- Loans4Less.com, Inc. (LFLS) CEOCFO Magazine Interview Highlights Solid Market Position
- Low Carbon Technologies International, Inc. (LWCTF) Plans to Announce 6 Month YTD Financials
- Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
- Rainbow Coral Corp. (RBCC) Opens Talks to Acquire Tech Innovators in $142 Billion Drug Delivery Market
- Solar Wind Energy Tower, Inc. (SWET) Receives Notice of Allowance of Patent titled "Atmospheric Energy Extraction Devices and Methods"
- StreamTrack, Inc. (STTK) Announces Alliance to Potentially Reach Over 300 Million Registered PPTV Users
- The Aristocrat Group Corp. (ASCC) Unveils Debut Spirits Brand RWB Vodka
- The Guitammer Company Inc. (GTMM) Teams Up With Warner Bros. and Legendary Picturesfor Summer Release of "Pacific Rim," From Oscar® Nominated Director, Guillermo del Toro
- VentriPoint Diagnostics Ltd. (VPTDF) Announces Closing of Private Placement and Proposed Issuance of Shares for Debt
- Viaspace, Inc. (VSPC) and AGRICORP Sign Joint Development Agreement for 12 MW Power Plant Co-located with 2,100 acre Giant King Grass Plantation in Nicaragua
- VistaGen Therapeutics, Inc. (VSTA) and Duke University Publish Results on Production of Functional 3D Human Heart Tissue